
Protect Pharmaceutical
(OTC) PRTT
Protect Pharmaceutical Financials at a Glance
Market Cap
$6.32M
Revenue (TTM)
$81.73M
Net Income (TTM)
$23.25M
EPS (TTM)
$0.86
P/E Ratio
0.13
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$0.11
Volume
31,115
Open
$0.10
Price
$0.11
Volume
31,115
Open
$0.10
Previous Close
$0.11
Daily Range
$0.10 - $0.11
52-Week Range
$0.02 - $1.18
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$0.11
Volume
31,115
Open
$0.10
Previous Close
$0.11
Daily Range
$0.10 - $0.11
52-Week Range
$0.02 - $1.18
Estimated Earnings Date
N/A
PRTT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Protect Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareCEO
Boris Stepanov
Website
www.protectpharma.comHeadquarters
Las Vegas, NV 89115, US
PRTT Financials
Key Financial Metrics (TTM)
Gross Margin
55%
Operating Margin
34%
Net Income Margin
28%
Return on Equity
15%
Return on Capital
8%
Return on Assets
5%
Earnings Yield
7.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.32M
Shares Outstanding
57.45M
Volume
31.11K
Avg. Volume
5.10K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$3.00K
EBITDA
-$3.00K
Operating Cash Flow
$12.71M
Capital Expenditure
-$2.53M
Free Cash Flow
$10.19M
Cash & ST Invst.
$73.94M
Total Debt
$3.83M
Protect Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$6.32M
N/A
Market Cap/Employee
$2.11M
N/A
Employees
3
N/A
Net Income
-$1.50K
-100.0%
EBITDA
-$1.50K
-100.0%
Quarterly Fundamentals
Total Cash
$75.76M
+20.2%
Total Debt
$4.41M
+14.1%
Accounts Receivable
$60.64M
-12.7%
Inventory
$124.77M
+50.3%
Long Term Debt
$0.00
N/A
Short Term Debt
$4.41M
+14.1%
Return on Assets
5.49%
N/A
Return on Invested Capital
8.05%
N/A
Free Cash Flow
-$4.57M
-276.9%
Operating Cash Flow
-$2.10M
-181.3%